Teva Pharmaceutical Industries ADR
(TEVA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Sales | 16,121,000 | 13,899,000 | 0 | 9,408,000 | 8,408,000 |
| Cost of Goods | 7,056,000 | 6,532,000 | N/A | 4,531,000 | 4,149,000 |
| Gross Profit | 9,065,000 | 7,367,000 | 5,968,000 | 4,877,000 | 4,259,000 |
| Operating Expenses | 5,194,000 | 4,962,000 | 786,000 | 2,482,000 | 2,067,000 |
| Operating Income | 3,871,000 | 2,405,000 | -786,000 | 2,395,000 | 2,192,000 |
| Other Income | -249,000 | -235,000 | 0 | -42,000 | -1,486,000 |
| Pre-tax Income | 3,622,000 | 2,170,000 | -786,000 | 2,353,000 | 706,000 |
| Income Tax | 283,000 | 166,000 | N/A | 397,000 | 155,000 |
| Net Income Continuous | 3,339,000 | 2,004,000 | 2,374,000 | 1,952,000 | 1,846,320 |
| Minority Interests | 8,000 | 4,000 | N/A | N/A | N/A |
| Net Income | $3,331,000 | $2,000,000 | $2,374,000 | $1,952,000 | $546,000 |
| EPS Basic Total Ops | 3.72 | 2.29 | 0.81 | 2.54 | 0.72 |
| EPS Basic Continuous Ops | 3.73 | 2.30 | 3.04 | 2.54 | 2.44 |
| EPS Diluted Total Ops | 3.67 | 2.23 | 0.78 | 2.38 | 0.69 |
| EPS Diluted Continuous Ops | 3.63 | 2.24 | 2.90 | 2.35 | 2.29 |
| EBITDA(a) | $4,848,000 | $3,313,000 | $-293,000 | $2,916,000 | $2,623,000 |